Progestins can attenuate the amplitude of pulsatile LH and FSH secretion; reduce the risk of HRT-associated bleeding; and demonstrate greater therapeutic efficacy in women with gynecological disorders such as adenomyosis, endometriosis, and uterine fibroids. The gene discussed is BRD2; the disease is adenomyosis.